XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Segment Information (Tables) | 6 Months Ended
--- | ---
Sep. 30, 2017
Segment Reporting [Abstract] |
Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals | Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
| Quarter Ended September 30, |  | Six Months Ended September 30,
(In millions) | 2017 |  | 2016 |  | 2017 |  | 2016
Revenues |  |  |  |  |  |  |
Distribution Solutions (1) |  |  |  |  |  |  |
North America pharmaceutical distribution and services | $ | 43,508 |  |  | $ | 41,375 |  |  | $ | 86,524 |  |  | $ | 82,586 |
International pharmaceutical distribution and services | 6,773 |  |  | 6,271 |  |  | 13,155 |  |  | 12,601 |
Medical-Surgical distribution and services | 1,660 |  |  | 1,631 |  |  | 3,193 |  |  | 3,099 |
Total Distribution Solutions | 51,941 |  |  | 49,277 |  |  | 102,872 |  |  | 98,286 |
Technology Solutions - products and services (2) | 120 |  |  | 680 |  |  | 240 |  |  | 1,404 |
Total Revenues | $ | 52,061 |  |  | $ | 49,957 |  |  | $ | 103,112 |  |  | $ | 99,690 |
Operating profit |  |  |  |  |  |  |
Distribution Solutions (3) (4) | $ | 388 |  |  | $ | 851 |  |  | $ | 1,101 |  |  | $ | 1,779 |
Technology Solutions (5) (6) | (33 | ) |  | (174 | ) |  | (111 | ) |  | (6 | )
Total | 355 |  |  | 677 |  |  | 990 |  |  | 1,773 |
Corporate Expenses, Net | (108 | ) |  | (74 | ) |  | (217 | ) |  | (179 | )
Interest Expense | (69 | ) |  | (78 | ) |  | (137 | ) |  | (157 | )
Income from Continuing Operations Before Income Taxes | $ | 178 |  |  | $ | 525 |  |  | $ | 636 |  |  | $ | 1,437 |
(1) | Revenues derived from services represent less than 2% of this segment’s total revenues.
(2) | 2018 revenues for the Technology Solutions segment only include the results of our EIS business. Effective April 1, 2017, our RHP business was transitioned from the Technology Solutions segment to the Distribution Solutions segment. The second quarter and first six months of 2017 included the majority of our Core MTS Business which was contributed to Change Healthcare on March 1, 2017.
(3) | Distribution Solutions operating profit for the second quarter and first six months of 2018 include pre-tax credits of $29 million and $3 million, and for the second quarter and first six months of 2017 include pre-tax credits of $43 million and pre-tax charges of $4 million related to our LIFO method of accounting for inventories. LIFO credits for the second quarters of 2018 and 2017 reflected the reversals of the LIFO expenses recorded in the first quarters of 2018 and 2017 due to a change in estimates relating to full year expectations for net price increases. LIFO credits for the first half of 2018 were primarily due to lower full year expectations for net price increases. Additionally, the first six months of 2017 included $142 million of net cash proceeds representing our share of net settlements of antitrust class action lawsuits against drug manufacturers.
(4) | Operating profit for our Distribution Solutions segment for the second quarter and first six months of 2018 includes a pre-tax gain of $43 million recognized from the sale of an equity investment. Additionally, the second quarter and first six months of 2018 for our Distribution Solutions segment include a pre-tax non-cash charge of $236 million primarily related to the impairment of certain long-lived assets and employee severance for our U.K. retail businesses, as well as a non-cash pre-tax goodwill impairment charge of $350 million for the McKesson Europe reporting unit.
(5) | Operating profit for our Technology Solutions segment for the second quarter and first six months of 2018 includes our EIS business and our proportionate share of loss from Change Healthcare of $61 million and $181 million. Additionally, operating profit for the first six months of 2018 includes a pre-tax gain of $37 million from the Healthcare Technology Net Asset Exchange related to the final net working capital and other adjustments.
(6) | The second quarter and first six months of 2017 include a non-cash pre-tax goodwill impairment charge of $290 million for the EIS reporting unit within our Technology Solutions segment.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration